sequencing and the management of adverse events when administering bispecifics for myeloma
Published 1 month ago • 32 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:21
sequencing of bcma-directed therapies for multiple myeloma
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
1:07
the value of bispecifics in myeloma & the importance of optimizing the sequencing of these agents
-
2:22
outcomes and management of patients with r/r myeloma who progress on bispecific antibodies
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
6:29
how are nk cells being used in anti-myeloma therapy?
-
1:10:18
science: discovering antibodies in months: new advances in ht-spr, single-cell bcr-seq and rna-seq
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:45
the advent of bispecific antibodies for multiple myeloma
-
1:44
optimal treatment sequencing in multiple myeloma
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
3:11
sequencing immunotherapies in multiple myeloma
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
9:13
treatment selection and sequencing for multiple myeloma
-
7:05
developments in the use of bispecific antibodies in myeloma and challenges in this space
-
2:54
using whole genome sequencing to track early events in multiple myeloma
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
0:53
the future of next-generation sequencing assays in myeloma treatment
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma